Table 3.
Incidence and hazard ratio of development of albuminuria.
| N | Event | Person-years | Incidence per 100 person-years (95% CI) | Crude hazard ratio (95% CI) | Adjusted hazard ratioa (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| Group 1 | 306 | 134 | 482.58 | 27.77 (23.07–32.47) | 1 | Reference | 1 | Reference |
| Group 2 | 1155 | 447 | 1864.62 | 23.97 (21.75–26.20) | 0.83 | (0.68–1.00) | 0.80 | (0.65–0.97) |
| Group 3 | 916 | 380 | 1396.62 | 27.22 (24.48–29.96) | 0.91 | (0.74–1.10) | 0.88 | (0.71–1.08) |
| Group 4 | 500 | 178 | 812.39 | 21.91 (18.69–25.13) | 0.74 | (0.59–0.93)b | 0.70 | (0.56–0.89)b |
a
Adjustment covariates: gender, age, duration of diabetes, HbA1c, eGFR, Cr, use of RASBs, CCBs and oral anti-diabetic drugs.
b
p< 0.05